Chelsea K Osterman
5PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Sep 01, 2021
Predictive Modeling for Adverse Events and Risk Stratification Programs for People Receiving Cancer Treatment.Chelsea K Osterman, Hanna K Sanoff, William A Wood
|Aug 24, 2021
Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer.Tracy L Rose, Michael R Harrison, Allison M Deal
|Oct 13, 2020
Risk stratification and outreach to hematology/oncology patients during the COVID-19 pandemic.Chelsea K Osterman, Tammy Triglianos, Gary S Winzelberg
|Sep 28, 2020
New and Emerging Therapies in the Management of Bladder Cancer.Chelsea K Osterman, Matthew I Milowsky
|Mar 26, 2020
Searching for the perfect combination of drug, disease, genetic alteration, and screening test to maximize FGFR inhibition in urothelial cancer.Chelsea K Osterman, Matthew I Milowsky
Pageof 1
Frequent Collaborators
2 joint publications
Matthew I Milowsky
1 joint publications
Tracy L Rose
1 joint publications
Michael R Harrison
1 joint publications
Allison M Deal
1 joint publications
Young E Whang
1 joint publications
Marc A Bjurlin
1 joint publications
Daniel George
1 joint publications
Tian Zhang
1 joint publications
William Y Kim
1 joint publications
Hanna K Sanoff
